Wells Fargo’s 1Life Healthcare ONEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-161,296
| Closed | -$2.7M | – | 7875 |
|
|
2022
Q4 | $2.7M | Buy |
161,296
+42,982
| +36% | +$726K | ﹤0.01% | 2548 |
|
|
2022
Q3 | $2.03M | Buy |
118,314
+102,671
| +656% | +$1.61M | ﹤0.01% | 2730 |
|
|
2022
Q2 | $123K | Sell |
15,643
-25,074
| -62% | -$215K | ﹤0.01% | 4532 |
|
|
2022
Q1 | $450K | Sell |
40,717
-40,944
| -50% | -$459K | ﹤0.01% | 4487 |
|
|
2021
Q4 | $1.44M | Buy |
81,661
+65,602
| +409% | +$1.27M | ﹤0.01% | 3815 |
|
|
2021
Q3 | $325K | Sell |
16,059
-11,540
| -42% | -$297K | ﹤0.01% | 4899 |
|
|
2021
Q2 | $912K | Sell |
27,599
-24,562
| -47% | -$927K | ﹤0.01% | 4267 |
|
|
2021
Q1 | $2.04M | Sell |
52,161
-71,022
| -58% | -$3.33M | ﹤0.01% | 3682 |
|
|
2020
Q4 | $5.38M | Buy |
123,183
+25,220
| +26% | +$862K | ﹤0.01% | 2677 |
|
|
2020
Q3 | $2.78M | Buy |
97,963
+68,082
| +228% | +$2.15M | ﹤0.01% | 3053 |
|
|
2020
Q2 | $1.09M | Sell |
29,881
-9,171
| -23% | -$258K | ﹤0.01% | 3748 |
|
|
2020
Q1 | $709K | Buy |
+39,052
| New | +$856K | ﹤0.01% | 3780 |
|
Wells Fargo's ONEM Position: Q1 2023 in Review
Wells Fargo sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 161,296 shares — an estimated $2.7M sold.
Wells Fargo first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $5.38M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.
- Wells Fargo reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
- Wells Fargo sold 161,296 1Life Healthcare shares in Q1 2023, an estimated $2.7M.
- Wells Fargo first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
- Wells Fargo's 1Life Healthcare position peaked at $5.38M in Q4 2020.
- 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.
Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.